Current chemistry analyzers measure ion concentration using ionselective electrodes; however, may differ in the specific technology at the bedside versus the central laboratory. Instruments utilized for point-of-care testing (POCT) at the bedside use direct ion-selective electrodes, whereas central-laboratory analyzers use indirect ion-selective electrodes. Under most circumstances, these instruments will deliver the same result; however, various substances can cause interferences in one or the other. An 18-year-old Hispanic woman with a history of immune thrombocytopenic purpura (ITP) presented at Children's National Medical Center (CNMC) with a severe headache and required intravenous immunoglobulin (IVIG) therapy. Because a discrepancy developed between her point-of-care and central-laboratory sodium values, another instrument was used to retest the central-laboratory plasma specimens. The results were more in agreement with those from the point-of-care instrument and revealed a unique interference in sodium measurement related to IVIG use.
*To whom correspondence should be addressed. msvirk@gmail.com indirect (diluted) ISE measurement. 2 Implementation of point-of-care instruments typically involves correlation with the central laboratory analyzers (Figure 2 ). However, when this aspect of method validation is performed, interferences that may affect each instrument differently are not typically assessed.
Herein, we present the case of an 18-year-old Hispanic woman with a history of idiopathic thrombocytopenic purpura (ITP) who had been admitted to the pediatric intensive care unit (ICU) at CNMC. The patient had been started on eltrombopag (Promacta; Novartis Pharmaceuticals Corporation) for her ITP just a few weeks previously and presented with a severe headache and concern for seizure activity. Eltrombopag is a thrombopoietin-receptor agonist used to treat various conditions that lead to thrombocytopenia, including chronic ITP. A computed tomography (CT) scan of the head showed an acute subarachnoid bleed. As a result, the patient was immediately transfused with platelets and boluses of 3% normal saline, given the concern for increased intracranial pressure. A follow-up magnetic resonance image (MRI) scan showed extensive venous clot impairing drainage, venous infarct, and hemorrhagic transformation. The patient developed uncal herniation, loss of brain stem reflexes, and diabetes insipidus. Her sodium levels may have initially increased due to hyperosmolar therapy; despite this, severe hypernatremia developed secondary to diabetes insipidus.
Over time, sodium-measurement discrepancies began to appear between the direct ISE and indirect ISE analyzers.
The clinical team consulted with the Division of Laboratory Medicine at CNMC, and it was discovered that the
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Figure 1
Diagram of ion-selective technology using 2 electrodes and a membrane that allows only a particular ion to pass into a solution. The potential difference between the electrodes is proportional to the concentration of that ion of interest.
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Figure 2
Sodium correlation study results between Dimension EXL (Siemens Healthcare) and epoc whole-blood gas analyzer (Siemens Healthcare), demonstrating no statistically significant difference in healthy subjects.
discrepancy appeared after administration of a large dose of intravenous immunoglobulin (IVIG). On identifying these discrepancies, the ICU attending physician posed a question to our department: "Which sodium value should be relied on in making clinical decisions?"
To evaluate sodium results from 2 different instruments typically used in our hospitalized patients, we used a third instrument to test residual plasma specimens from the central laboratory. This instrument, the Radiometer ABL800 FLEX (Radiometer Medical), uses direct ISE methodology and is associated with few interferences. 3 The Radiometer ABL800 FLEX analyzer has been shown to correlate with indirect ion-selective membrane analyzers under normal conditions, within the limits specified by the United States Clinical Laboratory Improvement Amendment (CLIA). 4 Previous specimens from the patient were selected, which contained enough residual plasma and had time-matched measurements from the direct ISE analyzer for comparison. Table 1 outlines the 3 instruments involved, type of specimen tested, method of measurement, and interferences.
Over the course of 3 days in the ICU, 5 specimens of plasma could be obtained, which satisfied the inclusion criteria listed earlier herein. A total of 130 g of IVIG (1 g/kg) was administered on March 10, 2016, immediately after the second data point in Figure 3 . As seen in Figure 3 , 
Figure 3
Comparison of sodium values using the epoc whole-blood gas analyzer (Siemens Healthcare; a bedside point-of-care instrument), the Dimension EXL (Siemens Healthcare; the central laboratory analyzer), and the Radiometer ABL800 FLEX (Radiometer Medical).
DOI: 10.1093/labmed/lmy025
sodium measurements were all in agreement for the second data point (156 mmol/L; CNMC reference range, 135-145 mmol/L) but diverged after the administration of IVIG. Sodium levels measured by the direct ISE analyzer (epoc whole-blood gas analyzer) began trending upward but were discordant with the results from the indirect ISE analyzer (Dimension XL; Siemens Healthcare). At the third data point, the difference between the Dimension XL and Radiometer values was 15 mmol per L. Although the epoc sodium level that was measured at the same time did not exactly match with the Radiometer measurements, it was clear that the epoc instrument better reflected the true hypernatremic state of the patient when taking the IVIG infusion into account. Also, the first and last specimens were tested for total protein levels, to demonstrate a rise due to IVIG. The first specimen tested, before therapy, had a total protein level of 8.0 g per dL, and the final specimen had a level of 9.6 g per dL. Although there was insufficient residual plasma to test the intervening specimens, these findings indicated a significant increase in total protein, likely resulting from IVIG therapy.
Discussion
Changes in blood protein, lipids, and other metabolites can affect accurate measurement of various plasma concentrations. Specifically, changes in the protein and lipid content will cause a change in the percentage of plasma water. Indirect ISE analyzers will assume a plasma water value of 93% and report ion concentrations based on a calculated adjustment. 5, 6 This calculated adjustment may be insufficient in patients with hyperlipidemia or hyperproteinemia. 7 Psuedohyponatremia and underestimation of hypernatremia have previously been described in patients receiving IVIG and also a case of true hyponatremia after this type of therapy. [8] [9] [10] [11] The difficulty is compounded by the fact that not every patient responds to IVIG therapy in the same way, so the resulting pseudohyponatremia can be widely variable. 12, 13 In 2015, Goldwasser et al 14 The true sodium concentration (as measured by direct ISE) was 157 mmol per L. The calculated correction, as shown above, indicated a sodium discrepancy of 1.12 mmol per L, whereas the actual observed discrepancy was 6 mmol per L. This finding serves as a prime example of why correction factors are unreliable and can lead to a gross underestimation of hypernatremia. Another study 15 additionally tried to correlate pseudohyponatremia with albumin, a major protein constituent of blood; however, the researchers were also unable to find consistent correlation.
Conclusion
Monitoring plasma sodium concentrations in critically ill patients requires accurate results for appropriate clinical decision making. In many of these patients, significant changes in protein levels due to IVIG infusion can affect the accuracy of sodium measurements via analyzers that use indirect ISE technology. In the case we have presented herein, the patient had an increasing sodium level according to both analyzers that were initially used in the evaluation. However, the severity of her hypernatremia was not correctly reflected by indirect ISE. Such a scenario can result in reduced urgency to treat and inadequate correction of electrolyte imbalances. Due to the variable effect of hyperproteinemia on serum sodium and the difficulty in standardizing a calculated adjustment, a measurement taken by an analyzer that uses direct ISE would be the most reliable in making clinical decisions. LM
